Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Valganciclovir × CNS × Clear all

Phase

Status

Recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Interventions

Temozolomide 63 Radiotherapy 37 Magnetic Resonance Spectroscopy 35 Radiosurgery 27 Specimen Handling 24 Cyclophosphamide 23 pembrolizumab 21 Nivolumab 20 Radiation 19 Carboplatin 14 Bevacizumab 13 Biopsy 12 Vincristine 11 Cisplatin 11 Ipilimumab 10 trametinib 9 X-Rays 9 Irinotecan 9 Immunoglobulin G 9 Etoposide 9 Topotecan 8 Lomustine 8 Disulfides 8 dinutuximab 7 AZD 6244 7 olaparib 6 atezolizumab 6 abemaciclib 6 Proton Therapy 6 Phantoms, Imaging 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116411 2025-12-22

VIGAS2

Karolinska Institutet

Phase 2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡